The Division of Molecular Medicine and Gene Therapy is located at the Biomedical Center (BMC), Lund University, Sweden. Established as a joint venture between the Medical Faculty at Lund University and the Hematology Clinic at Lund University Hospital, our mission is to translate basic science to clinical applications.
Our research focuses on hematopoiesis, the continuous and dynamic process of blood cell formation. The laboratory consists of eight closely collaborating research groups that all share a common interest in investigating the properties of blood stem cells to eventually understand and treat hematological disorders.
Five of our researchers belong to the Hemato-Linné Excellence Linnaeus Research Environment funded by The Swedish Research Council and Lund University. Several of the groups are engaged in StemTherapy, a Strategic Research Area for Stem Cells and Regenerative Medicine that is also supported by The Swedish Research Council.
One postdoctoral fellow position is available in Dr. Kenichi Miharada’s research group. Dr. Miharada's research interest is to discover novel regulatory machineries of hematopoietic stem cells (HSCs), particularly focusing on protein quality control and metabolic regulation. Read more about his research here.
Each year UniStem organizes a big outreach event on stem cells dedicated to high school students. In 2014 the event was organized simultaneously by 47 universities across Italy, Spain, Ireland, Sweden and UK and the plan is to get even more universities across Europe involved for 2015. This year Lund Stem Cell Center, via the Research School, will organize UniStem Day in Lund! The event will take place on Friday March 13th.
Congratulations to Jonas Larsson who was recently awarded an ERC Consolidator Grant. Of the 2,525 applications received from all over Europe, 372 were awarded funding. Jonas Larsson is one out of nine Swedish researchers who received an ERC Consolidator Grant 2014. He was awarded € 2 million for his research on "Uncovering Targets for Ex Vivo Expansion of Hematopoietic Stem Cells to Enhance Cell Therapies of Blood Disorders (UNEXPECTED)".
Researchers at Lund University have identified a previously unknown effect of vitamin A during fetal development.
The results show that vitamin A affects the formation of blood cells that occurs during human embryonic development.
Professor Xiaolong Fan from Beijing Normal University, China, will hold a lecture entitled “Molecular Classification of Glioma” on February 11 at 14:00 in Segerfalk lecture hall, BMC A10. Professor Fan’s laboratory has recently published a paper in PNAS (2014) describing key findings in the molecular classification of glioma. Xiaolong Fan has been a member of the Division of Molecular Medicine between 1997 and 2001 where he mainly focused on the development of adenoviral vector-mediated gene transfer into human hematopoietic cells.